Stephenson Pamela
Chief Commercial Officer at IRON; Director at Zynerba Pharmaceuticals, Inc.; Chief Commercial Officer at Biodel Inc
- Sold, on record
- $794k
- Dollars the filings state
- Form 4 sales
- 22
- Latest Feb 17, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- IRONDisc Medicine, Inc.Chief Commercial Officer
- Zynerba Pharmaceuticals, Inc.Director
- Biodel IncChief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Biodel Inc9,345 shares
- IRON8,668 shares
- Zynerba Pharmaceuticals, Inc.155 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Biodel IncPlan not statedSep 26, 2022 2022
Sold 445 shares at $19.40 ($9k)
Stephenson Pamela, Chief Commercial Officer
Sold 1% of holdings ($896k position)45,751 shares left1x usual sizeFiling
- 2 Form 4 sale Biodel IncPlan not statedOct 24, 2022 +28 days
Sold 104 shares at $19.58 ($2k)
Stephenson Pamela, Chief Commercial Officer
Sold 0.2% of holdings ($896k position)45,647 shares left0.2x usual sizeFiling
- 3 Form 4 sale Biodel IncPlan not statedDec 27, 2022 +64 days
Sold 469 shares at $19.06 ($9k)
Stephenson Pamela, Chief Commercial Officer
Sold 1% of holdings ($870k position)45,178 shares left1x usual sizeFiling
- 4 Form 4 sale Biodel IncUnusualJan 19, 2023 +23 days
Sold 1,774 shares at $43.90 ($78k)
Stephenson Pamela, Chief Commercial Officer
Sold 4% of holdings ($2M position)42,857 shares left4x usual sizeFiling
- 5 Form 4 sale Biodel IncPlan not statedJan 23, 2023 +4 days
Sold 102 shares at $43.80 ($4k)
Stephenson Pamela, Chief Commercial Officer
Sold 0.2% of holdings ($1.9M position)42,755 shares left0.2x usual sizeFiling
- 6 Form 4 sale Zynerba Pharmaceuticals, Inc.No planJun 14, 2023 +142 days
Sold 115 shares at $0.35 ($40)
Stephenson Pamela, Director
No 10b5-1 planSold 0.2% of holdings ($27k position)75,778 shares leftFiling
- 7 Form 4 sale IRONNo planFeb 18, 2025 +615 days
Sold 3,137 shares at $54.58 ($171k)
Stephenson Pamela, Chief Commercial Officer
No 10b5-1 planSold 4.3% of holdings ($4M position)69,529 shares leftFirst sale on recordFiling
- 8 Form 4 sale IRONNo planFeb 17, 2026 +364 days
Sold 5,531 shares at $62.86 ($348k)
Stephenson Pamela, Chief Commercial Officer
No 10b5-1 planSold 6.4% of holdings ($5.4M position)80,998 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (22)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 17, 2026 | IRON | Chief Commercial Officer | Form 4 sale | 5,531 | $348k | 6.4% | No plan | SEC |
| Feb 18, 2025 | Feb 20, 2025 | IRON | Chief Commercial Officer | Form 4 sale | 3,137 | $171k | 4.3% | No plan | SEC |
| Jun 14, 2023 | Jun 15, 2023 | Zynerba Pharmaceuticals, Inc. | Director | Form 4 sale | 115 | $40 | 0.2% | No plan | SEC |
| Jan 23, 2023 | Jan 23, 2023 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 102 | $4k | 0.2% | Plan not stated | SEC |
| Jan 19, 2023 | Jan 20, 2023 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 1,774 | $78k | 4.0% | Unusual | SEC |
| Dec 27, 2022 | Dec 27, 2022 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 469 | $9k | 1.0% | Plan not stated | SEC |
| Oct 24, 2022 | Oct 25, 2022 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 104 | $2k | 0.2% | Plan not stated | SEC |
| Sep 26, 2022 | Sep 27, 2022 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 445 | $9k | 1.0% | Plan not stated | SEC |
| Jul 22, 2022 | Jul 25, 2022 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 106 | $3k | 0.2% | Plan not stated | SEC |
| Jun 27, 2022 | Jun 28, 2022 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 461 | $9k | 1.0% | Plan not stated | SEC |
| Jun 14, 2022 | Jun 16, 2022 | Zynerba Pharmaceuticals, Inc. | Director | Form 4 sale | 40 | $40 | 0.1% | Plan not stated | SEC |
| Apr 22, 2022 | Apr 25, 2022 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 103 | $3k | 0.2% | Plan not stated | SEC |
| Mar 28, 2022 | Mar 29, 2022 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 454 | $14k | 1.0% | Plan not stated | SEC |
| Jan 24, 2022 | Jan 25, 2022 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 416 | $10k | 0.9% | Plan not stated | SEC |
| Dec 27, 2021 | Dec 27, 2021 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 474 | $11k | 1.8% | Plan not stated | SEC |
| Sep 27, 2021 | Sep 28, 2021 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 451 | $14k | 1.7% | Plan not stated | SEC |
| Jun 25, 2021 | Jun 28, 2021 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 471 | $17k | 1.7% | Plan not stated | SEC |
| Mar 29, 2021 | Mar 31, 2021 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 422 | $14k | 1.5% | Plan not stated | SEC |
| Dec 28, 2020 | Dec 29, 2020 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 460 | $18k | 2.1% | Plan not stated | SEC |
| Sep 25, 2020 | Sep 25, 2020 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 451 | $15k | 2.0% | Plan not stated | SEC |
| Jun 25, 2020 | Jun 26, 2020 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 397 | $12k | 1.7% | Plan not stated | SEC |
| Mar 25, 2020 | Mar 25, 2020 | Biodel Inc | Chief Commercial Officer | Form 4 sale | 1,785 | $31k | 7.1% | Plan not stated | SEC |